Health Catalyst HCAT Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 48.7%+2.8pp | 45.9%+1.4pp | 44.5%-3.7pp | 48.2%-0.4pp | |
| Operating margin | -51.7%-28.9pp | -22.8%+20.1pp | -42.9%+7.8pp | -50.7%+8.7pp | |
| Net margin | -57.2%-34.5pp | -22.7%+17.3pp | -39.9%+9.8pp | -49.7%+13.6pp | |
| Returns | |||||
| Return on equity | -58.3%-39.3pp | -19%+10.9pp | -29.8%-0.8pp | -29%+9.4pp | |
| Return on invested capital | -36.4%-22.8pp | -13.6%+10.2pp | -23.8%+1.9pp | -25.7%+5.8pp | |
| Efficiency | |||||
| Asset turnover | 0.5×+0.1× | 0.4×0.0× | 0.4×+0.1× | 0.3×0.0× | |
| Liquidity | |||||
| Current ratio | 1.9×+0.5× | 1.4×-3.0× | 4.4×-0.8× | 5.2×-0.3× | |
| Leverage | |||||
| Debt-to-equity | 0.7×-0.4× | 1.1×+0.4× | 0.7×+0.1× | 0.6×+0.2× | |
| Per Share | |||||
| Book value per share | $3.52-42.1% | $6.07-6.7% | $6.50-17.2% | $7.86-28.5% | |
| Valuation | |||||
| Market capitalization | $147.05M-43.6% | $430.19M-19.3% | $532.92M-8.4% | $582M-71.8% | |
| Price / sales | 0.5×-0.3× | 1.4×-0.4× | 1.8×-0.3× | 2.1×-6.4× | |
| Price / book | 1.1×+0.3× | 1.2×-0.3× | 1.5×+0.1× | 1.4×-2.6× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Health Catalyst's profit margins?
- Health Catalyst (HCAT) runs a 49.9% gross margin and a -81.7% operating margin, with a -87.7% net margin.
- Where do Health Catalyst's ratios come from?
- Every ratio is computed from Health Catalyst's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
